Author: United States. Congress. House. Committee on Ways and Means. Subcommittee on HealthPublisher:
ISBN:
Category : Law
Languages : en
Pages : 84
Book Description
The Administration's Prescription Drug Proposal
Author: United States. Congress. House. Committee on Ways and Means. Subcommittee on HealthPublisher:
ISBN:
Category : Law
Languages : en
Pages : 84
Book Description
The Administration's Prescription Drug Proposal
Author: United States House of RepresentativesPublisher:
ISBN:
Category :
Languages : en
Pages : 80
Book Description
The administration's prescription drug proposal: hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Sixth Congress, second session, May 11, 2000.
Making Medicines Affordable
Author: National Academies of Sciences, Engineering, and MedicinePublisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Administration's FY 2003 Budget Proposal for Prescription Drugs
Author: United States. Congress. Senate. Committee on FinancePublisher:
ISBN:
Category : Aged
Languages : en
Pages : 142
Book Description
THE ADMINISTRATION'S PRESCRIPTION DRUG PROPOSAL... HEARING... SERIAL 106-104... COMMITTEE ON WAYS AND MEANS..., 106TH CONGRESS, 2ND SESSION.
Author: The administration's prescription drug proposal
Author: United States. Congress. House. Committee on Ways and Means. Subcommittee on HealthPublisher:
ISBN:
Category : Law
Languages : en
Pages : 74
Book Description
A CBO Analysis of the Administration's Prescription Drug Proposal
Author: Dan L. CrippenIssues in Designing a Prescription Drug Benefit for Medicare
Author: The Role of NIH in Drug Development Innovation and Its Impact on Patient Access
Author: National Academies of Sciences, Engineering, and MedicinePublisher: National Academies Press
ISBN: 0309498511
Category : Medical
Languages : en
Pages : 103
Book Description
To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24â€"25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop.
Prescription Drugs
Author: United States. Congress. House. Committee on Commerce. Subcommittee on Health and the EnvironmentPublisher:
ISBN:
Category : Aged
Languages : en
Pages : 174
Book Description